News

The offering is expected to close on February 29, 2008. In connection with the offering, the company has also agreed to issue warrants to purchase an additional one

US health-care spending which was $2.2 trillion in 2007 is predicted to grow annually by about 6.7% for the next decade. GDP by contrast is expected to rise

The environment commissioner Stavros Dimas said that the main objective was to reduce the need for animal tests and promote alternative methods. The commission also maintained that it

The study showed that in comparison to placebo effects, antidepressants do not have clinically significant effects in mildly depressed patients or in most patients who suffer from very

Under the terms of the agreement, Shasun grants Merck the use of its proprietary cross-coupling copper technology (also known as Buchwald technology) to manufacture and commercialize APIs (active

Tentative FDA approval indicates that the FDA has concluded that Covidien’s generic product is safe and effective for use as recommended in the submitted labeling. Final approval of

As a result of this closing, Manhattan has received a $2 million cash payment plus $2.5 million of equity in the newly established joint venture, which has been

Under a collaborative research and exclusive license agreement, Receptor Logic will create custom TCRm in support of Sanofi Pasteur’s vaccine programs. Receptor Logic is funded and managed by

Under this CTA, Guiseppe Giaccone, chief of the medical oncology branch at NCI and his colleague, Martin Gutierrez, will conduct a Phase I clinical trial with Serenex’s novel,